Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Our new book is a comprehensive look at a vital part of medicines development and regulatory affairs. Grab your copy today!
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
| 18 June 2012 | By Ansis Helmanis,
Brazil's national regulatory agency, Anvisa, and the Ministry of health have announced the joint recognition of regulation as a benefit for social and economic development under a new Memorandum of Understanding published 13 June.
Anvisa had argued on behalf of the arrangement, saying its surveillance activities were "strategic" and worked to advance more than just good products. "Every step we take in the surveillance area, multiply the reduction of spending sustainability giving assistance to the health system," Anvisa's CEO, Dirceu Barbano, said in a statement.
Barbano said the agenda is a "priority" within Anvisa, and said he sees the agency's actions as more than just a buffer between "people who consume products and services and industry."
Read more:
Anvisa - Activity monitoring is needed to support SUS
More Breaking News from RegLink
Tags: MOU, brazil, regulatory